ASX/SLD (ASX/SLD)

Australian Securities Exchange: ASX/SLD · AUD

A$0.26

-0.01 (-3.8%)· Recorded snapshot

Market cap	64.3M
Revenue (ttm)	130.3M
Net income (ttm)	-346.4M
EPS (ttm)	-A$2.14
Shares out	252M
Volume	601,817

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 130.3M
Net income (ttm): -346.4M
EPS (ttm): -A$2.14
Market cap: 64.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROEn/a

P25 -108P50 -50.6P75 1.1

ROIC-71.1

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/SLD indicators

Market & fundamental data

Available fields

156

Groups with data

Currency

USD

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	United States
Country code	AU
Earnings date	2026-11-25
Employees	133
Enterprise value	AUD 40.2M
Exchange	Australian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2011
Industry	Medical Devices
Is primary listing	Yes
ISIN number	AU0000432114
Last earnings date	2026-07-30
Last refreshed	2026-10-29
Market cap	AUD 64.3M
Next earnings date	2026-11-25
Price	AUD 0.26
Price currency	AUD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-29
Symbol	asx/SLD
Website	https://www.saludamedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-837.62%
EV/Sales	0.31x
FCF / EV yield	-419.4%
FCF yield	-262.54%
P/B ratio	0.81x
P/S ratio	0.49x
Price / tangible book value	0.81x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-160.24%
EBITDA margin	-158.23%
Gross margin	48.89%
Operating margin	-160.24%
Pretax margin	-165.09%
Profit margin	-165.87%
Profit per employee	AUD -2.6M
Revenue per employee	AUD 980,060
ROA	-56.97%
ROCE	-93.01%
ROIC	-71.14%
SBC / revenue	30.93%
Tax / revenue	0.78%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	34.58%
Gross profit growth (Q)	46.07%
Revenue growth	28.17%
Revenue growth (Q)	38.44%
Revenue growth (QoQ)	29.08%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -1.1M
Depreciation and amortization	AUD 2.6M
EBIT	AUD -208.9M
EBITDA	AUD -206.3M
EPS	AUD -2.14
FCF per share	AUD -0.67
Financing cash flow	AUD 262.1M
Free cash flow	AUD -168.7M
Free cash flow minus SBC	AUD -209M
Gross profit	AUD 63.7M
Income taxes	AUD 1M
Investing cash flow	AUD -1.1M
Net borrowing	AUD 34.9M
Net cash flow	AUD 92.7M
Net income	AUD -346.4M
Operating cash flow minus SBC	AUD -208M
Operating income	AUD -208.9M
Revenue	AUD 130.3M
Stock-based compensation	AUD 40.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.82
Book value per share	AUD 0.31
Debt / equity	1.83
Interest coverage	-15.34
Long-term assets	AUD 17.5M
Long-term liabilities	AUD 146.5M
Net cash (debt)	AUD 24M
Net cash / market cap	37.4%
Net debt / equity	-0.3
Piotroski F-Score	4
Property, plant and equipment	AUD 9.7M
Shareholders' equity	AUD 78.9M
Tangible book value	AUD 78.9M
Tangible book value per share	AUD 0.31
Total assets	AUD 272.3M
Total cash	AUD 168.2M
Total debt	AUD 144.2M
Total liabilities	AUD 193.5M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	AUD 254.8M
Current liabilities	AUD 46.9M
Current ratio	5.43
Inventory turnover	1.22
Net working capital	AUD 45M
Quick ratio	4.14
Working capital	AUD 211.5M
Working capital turnover	2.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4,887.27%
Shareholder yield	-4,887.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.49
1D price change	-3.77%
1M price change	-36.59%
1M total return	-36.59%
1W price change	-1.89%
1W total return	-1.89%
20-day SMA	AUD 0.34
200-day SMA	AUD 0.62
3M price change	-36.59%
3M total return	-36.59%
50-day SMA	AUD 0.41
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 2.65
52-week high date	2025-12-04
52-week low	AUD 0.25
52-week low date	2026-10-28
6M price change	-58.4%
6M total return	-58.4%
All-time high	AUD 2.65
All-time high date	2025-12-03
All-time low	AUD 0.25
All-time low date	2026-10-26
Average true range (ATR)	AUD 0.02
Average volume	301.8K
Beta (1Y)	0.95
Change from 52-week high	-90.38%
Change from 52-week low	2%
Change from all-time high	-90.19%
Change from all-time low	4%
Change from open	-3.77%
Day's gap	0%
Dollar volume	AUD 153,463
High price	AUD 0.27
Low price	AUD 0.26
Monthly RSI	0
Open price	AUD 0.27
Position in 52-week range	0%
Previous close	AUD 0.27
Price vs 150-day SMA	-46.9%
Price vs 20-day SMA	-24.53%
Price vs 200-day SMA	-58.34%
Price vs 50-day SMA	-36.41%
Relative volume	1.99
RSI	23.91
Sharpe ratio	-2
Sortino ratio	-2.42
Volume	601.8K
Weekly RSI	29.67
YTD price change	-81.75%
YTD total return	-81.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106.9M
Shares change (QoQ)	239.7%
Shares change (YoY)	4,887.27%
Shares held by insiders	2.3%
Shares held by institutions	46.16%
Shares outstanding	252M

Deeper analysis on ASX/SLD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/SLD report

Is a complete ASX/SLD research report available?

No complete published report is available for asx/SLD (ASX/SLD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/SLD (ASX/SLD)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/SLD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/SLD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/SLD

Frequently asked questions